FCHSD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.791800E-01
Normal-vs-Stage2
3.066000E-01
Normal-vs-Stage3
2.253800E-01
Normal-vs-Stage4
2.259800E-01
Stage1-vs-Stage2
5.479800E-01
Stage1-vs-Stage3
9.166000E-02
Stage1-vs-Stage4
2.838600E-01
Stage2-vs-Stage3
1.922850E-03
Stage2-vs-Stage4
5.472800E-01
Stage3-vs-Stage4
1.254990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.981800E-01
Normal-vs-AfricanAmerican
3.522800E-01
Normal-vs-Asian
2.753000E-01
Caucasian-vs-AfricanAmerican
3.828600E-01
Caucasian-vs-Asian
4.653400E-01
AfricanAmerican-vs-Asian
2.394000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.918400E-01
Normal-vs-Female
3.098800E-01
Male-vs-Female
3.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.640400E-01
Normal-vs-Age(41-60Yrs)
3.219200E-01
Normal-vs-Age(61-80Yrs)
2.936200E-01
Normal-vs-Age(81-100Yrs)
2.704800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.434400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.471600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.500200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.229400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.332400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.879400E-01
Normal-vs-Daily Drinker
2.722200E-01
Normal-vs-Weekly Drinker
2.892400E-01
Normal-vs-Occasional Drinker
2.789000E-01
Normal-vs-Social Drinker
3.092400E-01
Non Drinker-vs-Daily Drinker
6.117600E-01
Non Drinker-vs-Weekly Drinker
9.866600E-01
Non Drinker-vs-Occasional Drinker
7.831000E-01
Non Drinker-vs-Social Drinker
6.172200E-01
Daily Drinker-vs-Weekly Drinker
6.315200E-01
Daily Drinker-vs-Occasional Drinker
8.011800E-01
Daily Drinker-vs-Social Drinker
3.427200E-01
Weekly Drinker-vs-Occasional Drinker
7.680400E-01
Weekly Drinker-vs-Social Drinker
6.569800E-01
Occasional Drinker-vs-Social Drinker
4.267200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.335000E-01
Normal-vs-Grade 2
6.647400E-01
Normal-vs-Grade 3
3.124200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.758000E-01
Grade 1-vs-Grade 3
5.513200E-01
Grade 1-vs-Grade 4
6.335000E-01
Grade 2-vs-Grade 3
4.012800E-01
Grade 2-vs-Grade 4
6.647400E-01
Grade 3-vs-Grade 4
3.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.078800E-01
Normal-vs-NonDiabetic
2.844800E-01
Diabetic-vs-NonDiabetic
3.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.970600E-01
Normal-vs-NoPancreatitis
2.935200E-01
Pancreatitis-vs-NoPancreatitis
8.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.978400E-01
Normal-vs-N1
3.034200E-01
N0-vs-N1
7.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.823800E-01
Normal-vs-TP53-NonMutant
3.037400E-01
TP53-Mutant-vs-TP53-NonMutant
4.253200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
